Alternate Health

Alternate Health Financing Cash Flow

The Net Financing Cash Flow of Alternate Health (AHGIF) as of Oct 25, 2026 is 9.22 M CAD. In the previous year, Net Financing Cash Flow was 11.18 M CAD — a change of -17.54% (lower).

Financing Cash Flow

9.22 MCAD

YoY

-17.54%

Last updated:

Net Financing Cash Flow of Alternate Health is 2018 9.22 M CAD. Net Financing Cash Flow of Alternate Health was 2017 11.18 M CAD. It decreases by -17.54% lower compared to the previous year.

The Alternate Health Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2016
1.30 M CAD
Jan 1, 2017
11.18 M CAD
Jan 1, 2018
9.22 M CAD
The Alternate Health Financing Cash Flow history
YEARFinancing Cash FlowYoY
9.22 MCAD-17.54%
11.18 MCAD+761.92%
1.30 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alternate Health Stock analysis

What does Alternate Health do? Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms. The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research. Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs. Alternate Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alternate Health stock

Net Financing Cash Flow of Alternate Health is 9.22 M CAD in 2018.

Net Financing Cash Flow of Alternate Health changed from 11.18 M CAD to 9.22 M CAD, representing a -17.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Alternate Health since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Alternate Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Alternate Health

All Key Metrics — Alternate Health